<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Meiogenix 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=17034></link><description><![CDATA[Meiogenix 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Thu, 14 May 2026 06:41:49 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><language>ko-KR</language><item><title><![CDATA[Meiogenix, 과학자문기구 구성을 발표하다]]></title><link>https://www.newswire.co.kr/newsRead.php?no=612013</link><description><![CDATA[프랑스 파리--(뉴스와이어)--감수결합 변조기술(SpiX®) 개발 유전체 바이오테크 기업인 Meiogenix는 과학자문기구(Scientific Advisory Board) 구성을 발표했다. Alain Nicolas박사가 SAB의 의장직을 맡으며 Holger Puchta교수와 Philip Avner교수가 합류한다.  Alain Nicolas박사는 파리에 있는 인스티튜트 퀴리 연구센터(Research Center of the Institut Curie)의 그룹 리더이다. Nicolas박사는 진핵...]]></description><pubDate>Sun, 25 Mar 2012 15:27:44 +0900</pubDate></item><item><title><![CDATA[Meiogenix Announces the Constitution of a Scientific Advisory Board]]></title><link>https://www.newswire.co.kr/newsRead.php?no=612014</link><description><![CDATA[PARIS, FRANCE--(Korea Newswire)--Meiogenix, a genomic biotech company developing a technology that modulates meiotic recombination (SpiX®), has announced the constitution of its Scientific Advisory Board. Dr. Alain Nicolas will chair the SAB, and is joined by Prof. Holger Puchta and Prof. Philip Avner.  Dr. Alain Nicolas is a group leader at the Research Center of the Institut ...]]></description><pubDate>Sun, 25 Mar 2012 15:26:31 +0900</pubDate></item></channel></rss>